MedPath

Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone

Not Applicable
Completed
Conditions
Postoperative
Hepato-Biliary Neoplasm
Nutritional Support
Interventions
Dietary Supplement: parenteral nutrition supplements
Dietary Supplement: enteral nutrition supplements
Dietary Supplement: mixed nutrition supplements
Registration Number
NCT06397430
Lead Sponsor
Karaganda Medical University
Brief Summary

A comprehensive comparative analysis of the effectiveness of isolated enteral, isolated parenteral and mixed type of nutritional support in the early postoperative period in patients after operations performed on the malignant neoplasms of hepatico-pancreatico-duodenal zone.

Detailed Description

A prospective, longitudinal, parallel study and retrospective analysis of the results of treatment of 91 patients with malignant tumors of the hepatico-pancreato-duodenal zone who underwent the following operations:

1. resection of various segments of the liver;

2. hemihepatectomy;

3. transhepatic drainage of the right and left hepatic duct;

4. bypass gastroenteroanastomosis or cholecystenteroanastomosis with interintestinal enteroenteroanastomosis according to Brown;

5. gastro-pancreato-duodenal resection;

6. corpore-caudal resection of the pancreas with splenectomy.

The first group (n=31) included patients who received enteral nutrition (EN) after surgery. The second group (n=30) included patients who received parenteral nutrition (PN) and the third group (n=30) who received mixed nutrition (MN), as a variation of the partial parenteral nutrition technique, in the early postoperative period.

Some nutritional status indicators available for determination at the Oncology Clinic were assessed - body mass index (weight measurements were carried out before surgery, on the 5th, 10th and 15th days), basal metabolic rate (calculated using the Harris-Benedict equation, based on anthropometric data of the patient (gender, age, weight and height).), laboratory parameters: blood hemoglobin, lymphocytes, total protein, serum albumin, serum transferrin, total bilirubin and direct, alanine aminotransferase (ALT), aspartate aminotransferase (AST), which are related to the traditional method for assessing nutritional status

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
91
Inclusion Criteria

female and male patients in age of 20-75 with malignant tumors of the hepato-pancreato-duodenal zone who have undergone any of the following operations:

  1. resection of various segments of the liver;
  2. hemihepatectomy;
  3. transhepatic drainage of the right and left hepatic duct;
  4. bypass gastroenteroanastomosis or cholecystoenteroanastomosis with interintestinal enteroenteroanastomosis according to Brown;
  5. gastro-pancreatoduodenal resection;
  6. corporecaudal resection of the pancreas with splenectomy.
Exclusion Criteria
  • patients in age of up to 20 and older than 75
  • pregnant and breastfeeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm 2 - parenteral nutritionparenteral nutrition supplementspatients receiving parenteral nutrition (PN)
Arm 1 - enteral nutritionenteral nutrition supplementspatients receiving enteral nutrition (EN) after surgery
Arm 3 - mixed nutritionmixed nutrition supplementspatients receiving mixed nutrition (MF)
Primary Outcome Measures
NameTimeMethod
Serum albumin in g/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: serum albumin in g/L

ALT in IU/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: ALT in IU/L

AST in IU/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: AST in IU/L

Total protein level in BloodDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: total protein in g/L

Number of Participants with changes of BMI in kg/m^2Day 0, Day 5, Day 10, Day15

Variables of Body mass index measured by Canadian Guidelines for Body Weight Classification in Adults

Serum transferrin in g/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: serum transferrin in g/L

Total bilirubin in mmol/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: total bilirubin in mmol/L

Direct bilirubin in mmol/LDay 0, Day 5, Day 10, Day15

Blood biochemical analysis: direct bilirubin in mmol/L

Basal Metabolic rateDay 0, Day 5, Day 10, Day15

basal metabolic rate according to the Harris-Benedict equation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karaganda Medical University

🇰🇿

Karaganda, Kazakhstan

© Copyright 2025. All Rights Reserved by MedPath